Cannabis Across Life: Teens

Adolescent and teenage years are essential times for learning, forming social bonds, and discovering your earliest identities. At this stage, peers heavily influence each other’s habits, activities, feelings, moods, and opinions. The distinction between teens using cannabis recreationally or medicinally is important, but it relies on complex socioeconomic factors, demographics, appropriate medical attention, and compassionate parenting.

Introducing minors to cannabis should only be done with medical supervision, requiring at least one or even two doctors’ recommendations in your state. There are many legitimate health reasons for minors to use cannabis. However, “recreational” use for teens isn’t just about having fun since there are still some deeply complicated health and social angles to consider. 

In this article, we’ll closely examine the fine line between therapeutic cannabis applications and problematic cannabis use in adolescents. If you’re a teen reading this, you’ll learn more about cannabis’ health effects and what problems you may be dealing with or run into. Learning how to live a balanced lifestyle with or without cannabis is essential for everyone.

Commonality 

Cannabis is the most widely-used, illicit drug in children and adolescents. The 2013-2023 CDC Youth Risk Behavior Survey reports that in 2023, 17% of high school students used cannabis in 30 days. 

Yet, you may be surprised that this percentage is actually down from 25% over the last decade since 2013. It may be thanks to states’ decriminalization and regulation efforts to keep cannabis out of kids’ hands, but this isn’t definitively proven yet.

Compare these figures to Veriheal’s demographic data, which indicates that only 221 qualified minors were certified for medical cannabis use in 2023, accounting for less than 1% of Veriheal’s total official medical cannabis patients that year. That’s still likely an underestimation for the entire US. Regardless, all this means there’s a good chance you’re a concerned parent looking for reassurance and information. 

If you just found out your teen uses cannabis, or if you find weed, edibles, or a vape pen in their room, you may be reasonably concerned. Without rushing to judgment or anger, there are several key considerations for tactfully approaching this delicate and complicated situation.

Peer Pressure

It’s actually normal that most cannabis users are introduced to cannabis by peers relatively early on, most often in late adolescence. However, the context is critical.

Social media enables self-made content to spread faster and more efficiently than ever before, with about 77% of high school students using social media several times a day. But the developing brains of teens are particularly susceptible to its influence, misinformation, and addicting principles. Teens’ underdeveloped sense of delayed gratification is a biological contributing factor. 

Another important consideration is the increasingly reduced perception of harm from relaxed policies and peers. Seeing friends openly using cannabis online or in person influences teens more dramatically. Close friendships and relationships may be threatened or bullied if one goes against the grain of their social circle or partner.

In the same CDC survey, 25% of LGBTQ+ high school students reported currently using cannabis. This is largely a reflection of heavier stigma, bullying, and isolation of a marginalized and disproportionately bullied community causing worse mental health outcomes. Nearly 3 in 10 were bullied at school, and 2 in 10 attempted suicide.

Unfortunately, the report also says LBGTQ+ students are more likely to be victims of violence, threats, sexual trauma, bullying, and more. These create significant health disparities like increased rates of depression, anxiety, suicide attempts, and abuse of alcohol, cannabis, opioids, and other substances. Acknowledging teen cannabis use as a desperate attempt to ease anxiety, depression, or an overwhelming social situation also alleviates judgment and enhances compassion and understanding.     

Effects of Cannabis Use in Teens

Medicinal Uses

Cannabis use in adolescence isn’t all harmful. If medically supervised and dosed properly, the right dose, frequency, route, and selection of cannabinoids make a world of difference for many children and adolescents. It actually isn’t surprising then that the most commonly reported conditions in medical cannabis recommendations for minors mirror that of adults, except with a greater prevalence of cancer. 

Some of the most common diagnoses for pediatric cannabis recommendations include:

• Anxiety
• Depression
• Cancer 
• Nausea and vomiting
• Chronic pain
• PTSD
• Epilepsy
• Headache
• Insomnia
• ADD and ADHD
• Crohn’s disease
• Muscle spasms

Today, about 3% of 11-15-year-olds use non-impairing CBD for similar health reasons. 

Cannabinoids like CBD, CBDV, THC, and even pharmaceutical THC forms (e.g., dronabinol) also show early, positive results on core symptoms in children and adolescents with autism. 

Keep in mind that there’s limited clinical data for medical cannabis in pediatrics. This stems mostly from practical difficulties with study recruitment, retention, stigma, institutional policies, regulations, cost, and legal barriers. 

Health Outcomes

If teens have unrestricted access to cannabis via friends or intoxicating hemp products online (i.e., delta-8, delta-10, THCP, etc.), then cannabis dependence, abuse, or cannabinoid hyperemesis syndrome may become concerning. Starting cannabis before age 18 is associated with:

• Increased risk of cannabis use disorder (CUD)
• Using or abusing other substances
• Anxiety disorders
• Car accidents
• Antisocial behavior
• Early school dropout

Cannabis does not appear to cause conduct problems, but it’s more likely to be used by those who either affiliate with cannabis-using peers, or who already have conduct problems. Working closely with clinicians, therapists, and educational specialists can help you work through and overcome these challenges as a holistic, supportive, and nonjudgmental team. Without effective medications for CUD, aside from perhaps CBD, psychosocial-based interventions are first-line.

Parents often wonder about the impact cannabis has on the developing brain and any lasting effects. Currently, preliminary neuroimaging shows structural alterations in the brains of adolescent cannabis users in these regions:

• Frontoparietal
• Frontolimbic
• Frontostriatal
• Cerebellar

The significance of these changes is still unclear, meaning we don’t know what these changes translate to in the long run. Famously, cognitive impairment is the most common or even sought-after side effect of THC, but the good news is that large, aggregated studies on teens show this effect is only short-term. Cognitive effects disappear within 72 hours after use, even among the heaviest users.  

Another commonly stereotyped misconception is cannabis and laziness. 2024 data show that cannabis may do the opposite, marginally increasing physical activity and reducing sedentary behavior in young to midlife adults. 

Smoking and Vaping Concerns

Cannabis smoke shares a lot of the same carcinogens and mutagens as tobacco smoke. Avoiding cannabis smoking is recommended to prevent adverse effects like cardiovascular, airway, and physical problems. Vaping, smoking, or otherwise consuming any tobacco or nicotine products is even more addicting and unsafe, and they should never be recommended, either.

Vaping cannabis oil or dabbing concentrates may rapidly increase tolerance and dependence risk compared to flower because of the high THC potency. Individuals with a genetic predisposition to psychotic or mood disorders should avoid THC at a young age and instead use CBD under medical supervision.

Online vape products carry potentially serious quality and safety concerns because they often contain impurities and unknown byproducts, requiring independent verification (COA). Semisynthetic hemp-based products like delta-8 can be impairing and habit-forming and may have unknown short and long-term health effects. So, monitoring online and credit card activity is crucial. 

If teens use medical cannabis, non-inhalation routes like tinctures and edibles are the best, long-term options for better controlling dose, route, frequency, and predictability of effects. They are also easier to set limits with.

Bottom Line

Cannabis and CBD use in teens can be healthy, moderated, and legitimately used for myriad health issues with your doctor’s approval and adequate supervision. However, cannabis abuse in teens is often a symptom of a larger societal problem or deeper personal issue.

Teens should feel empowered and free to have open and regular conversations with adults and trusted healthcare professionals about what’s going on in their lives. 

Opening yourself up to better understand their world and vulnerability can help you develop trust and rapport for a healthy relationship with each other – and cannabis – moving forward.

References

1. Alirezaei, T., Mohammadi, M. K. A., Irilouzadian, R., & Zarinparsa, H. (2022). Marijuana-induced myocarditis in a 24-year-old man. Archive of Clinical Cases, 9(2), 69–74. https://doi.org/10.22551/2022.35.0902.10206
2. Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. (2022). Autism and associated disorders: Cannabis as a potential therapy. Frontiers in Bioscience-Elite, 14(1), Article 1. https://doi.org/10.31083/j.fbe1401001
3. Barrales-Cureño, H. J., López-Valdez, L. G., Reyes, C., Cetina-Alcalá, V. M., Vasquez-García, I., Diaz-Lira, O. F., & Herrera-Cabrera, B. E. (2020). Chemical Characteristics, Therapeutic Uses, and Legal Aspects of the Cannabinoids of Cannabis sativa: A Review. Brazilian Archives of Biology and Technology, 63, e20190222. https://doi.org/10.1590/1678-4324-2020190222
4. Carvalho, A. F., Stubbs, B., Vancampfort, D., Kloiber, S., Maes, M., Firth, J., Kurdyak, P. A., Stein, D. J., Rehm, J., & Koyanagi, A. (2019). Cannabis use and suicide attempts among 86,254 adolescents aged 12-15 years from 21 low- and middle-income countries. European Psychiatry: The Journal of the Association of European Psychiatrists, 56, 8–13. https://doi.org/10.1016/j.eurpsy.2018.10.006
5. CDC. (2024a). Youth Risk Behavior Survey Data Summary & Trends Report: 2013-2023. https://www.cdc.gov/yrbs/dstr/pdf/YRBS-2023-Data-Summary-Trend-Report.pdf
6. CDC. (2024b, August 6). CDC Data Show Improvements in Youth Mental Health but Need for Safer and More Supportive Schools. CDC Newsroom. https://www.cdc.gov/media/releases/2024/p0806-youth-mental-health.html
7. Chu, F., & Cascella, M. (2024). Cannabinoid Hyperemesis Syndrome. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK549915/
8. Coley, R. L., Carey, N., Kruzik, C., Hawkins, S. S., & Baum, C. F. (2024). Recreational Cannabis Legalization, Retail Sales, and Adolescent Substance Use Through 2021. JAMA Pediatrics, 178(6), 622–625. https://doi.org/10.1001/jamapediatrics.2024.0555
9. Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021). Cannabis use and cannabis use Disorder. Nature Reviews. Disease Primers, 7(1), 16. https://doi.org/10.1038/s41572-021-00247-4
10. Defoe, I. N., Khurana, A., Betancourt, L. M., Hurt, H., & Romer, D. (2019). Disentangling longitudinal relations between youth cannabis use, peer cannabis use, and conduct problems: Developmental cascading links to cannabis use disorder. Addiction, 114(3), 485–493. https://doi.org/10.1111/add.14456
11. Dellazizzo, L., Potvin, S., Giguère, S., & Dumais, A. (2023). The Potential Paradoxical Neurocognitive Effects of Cannabis Use in Patients with Psychotic Disorders: A Critical Meta-Review of Meta-Analytical Evidence. Cannabis and Cannabinoid Research, 8(3), 464–475. https://doi.org/10.1089/can.2021.0163
12. Doucette, M. L., Hemraj, D., Bruce, D., Fisher, E., & Macfarlan, D. L. (2024). Medical Cannabis Patients Under the Age of 21 in the United States: Description of Demographics and Conditions from a Large Patient Database, 2019-2023. Adolescent Health, Medicine and Therapeutics, 15, 63–72. https://doi.org/10.2147/AHMT.S460560
13. Efron, D., Freeman, J. L., Cranswick, N., Payne, J. M., Mulraney, M., Prakash, C., Lee, K. J., Taylor, K., & Williams, K. (2021). A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability. British Journal of Clinical Pharmacology, 87(2), 436–446. https://doi.org/10.1111/bcp.14399
14. Fletcher, S., Pawliuk, C., Ip, A., Huh, L., Rassekh, S. R., Oberlander, T. F., & Siden, H. (2022). Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review. Child: Care, Health and Development, 48(1), 33–44. https://doi.org/10.1111/cch.12909
15. Geci, M., Scialdone, M., & Tishler, J. (2023). The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ8-THC. Cannabis and Cannabinoid Research, 8(2), 270–282. https://doi.org/10.1089/can.2022.0126
16. Hammond, C. J., Chaney, A., Hendrickson, B., & Sharma, P. (2020). Cannabis use among U.S. adolescents in the Era of Marijuana Legalization: A review of changing use patterns, comorbidity, and health correlates. International Review of Psychiatry (Abingdon, England), 32(3), 221–234. https://doi.org/10.1080/09540261.2020.1713056
17. Harte-Hargrove, L. C., & Dow-Edwards, D. L. (2012). Withdrawal from THC during Adolescence: Sex Differences in Locomotor Activity and Anxiety. Behavioural Brain Research, 231(1), 48–59. https://doi.org/10.1016/j.bbr.2012.02.048
18. Midgette, G., & Reuter, P. (2020). Has cannabis use among youth increased after changes in its legal status? A commentary on use of Monitoring the Future for analyses of changes in state cannabis laws. Prevention Science : The Official Journal of the Society for Prevention Research, 21(1), 137–145. https://doi.org/10.1007/s11121-019-01068-4
19. Miller, C. R., Burk, B. G., Fargason, R. E., & Birur, B. (2023). Delta-8-THC association with psychosis: A case report with literature review. Frontiers in Psychiatry, 14, 1103123. https://doi.org/10.3389/fpsyt.2023.1103123
20. Page, R. L., Allen, L. A., Kloner, R. A., Carriker, C. R., Martel, C., Morris, A. A., Piano, M. R., Rana, J. S., & Saucedo, J. F. (2020). Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation, 142(10), e131–e152. https://doi.org/10.1161/CIR.0000000000000883
21. Pinto, J. V., Saraf, G., Frysch, C., Vigo, D., Keramatian, K., Chakrabarty, T., Lam, R. W., Kauer-Sant’Anna, M., & Yatham, L. N. (2020). Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 65(4), 213–227. https://doi.org/10.1177/0706743719895195
22. Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019). Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology. Molecules, 24(7), 1350. https://doi.org/10.3390/molecules24071350
23. Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F. G., Moore, T. M., & Gur, R. C. (2018). Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults. JAMA Psychiatry, 75(6), 585–595. https://doi.org/10.1001/jamapsychiatry.2018.0335
24. Siracusa, L., Ruberto, G., & Cristino, L. (2023). Recent Research on Cannabis sativa L.: Phytochemistry, New Matrices, Cultivation Techniques, and Recent Updates on Its Brain-Related Effects (2018–2023). Molecules, 28(8), 3387. https://doi.org/10.3390/molecules28083387
25. Testai, F. D., Gorelick, P. B., Aparicio, H. J., Filbey, F. M., Gonzalez, R., Gottesman, R. F., Melis, M., Piano, M. R., Rubino, T., & Song, S. Y. (2022). Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association. Stroke, 53(4), e176–e187. https://doi.org/10.1161/STR.0000000000000396
26. Villanueva, M. R. B., Joshaghani, N., Villa, N., Badla, O., Goit, R., Saddik, S. E., Dawood, S. N., Rabih, A. M., Niaj, A., Raman, A., Uprety, M., Calero, M., & Khan, S. (2022). Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review. Cureus, 14(7), e26913. https://doi.org/10.7759/cureus.26913
27. Wade, N. E., Nguyen-Louie, T. T., Wallace, A. L., Sullivan, R. M., & Tapert, S. F. (2024). Commercial Cannabidiol for Community-Based Young Adolescents: Predicting Medicinal Use. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2024.0015
28. White, C. M. (2017). The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids. The Journal of Clinical Pharmacology, 57(3), 297–304. https://doi.org/10.1002/jcph.827
29. Xue, Y., Diep, C., Zhao, H. J., Wijeysundera, D. N., Clarke, H., & Ladha, K. S. (2024). Recent Cannabis Use and Accelerometer-Measured Physical Activity and Sedentary Behavior Among Young-to-Midlife Adults: An Analysis of the National Health and Nutrition Examination Survey from 2011 to 2014. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2023.0244
30. Zehra, A., Burns, J., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G.-J. (2018). Cannabis Addiction and the Brain: A Review. Journal of Neuroimmune Pharmacology, 13(4), 438–452. https://doi.org/10.1007/s11481-018-9782-9